Stay updated on Pegcetacoplan in ALS Adults: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Pegcetacoplan in ALS Adults: Efficacy & Safety Clinical Trial page.

Latest updates to the Pegcetacoplan in ALS Adults: Efficacy & Safety Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe web page has been updated to include new results and assessments related to the Combined Assessment of Function and Survival (CAFS) and treatment-emergent adverse events (TEAEs) for a study on ALS, while previous data regarding the same metrics has been removed.SummaryDifference91%
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe page has been updated to include the term 'Amyotrophic Lateral Sclerosis' and the new revision number 'v2.15.0', while significant details about a Phase 2 study and its criteria have been removed.SummaryDifference15%
- Check39 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check46 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check75 days agoChange DetectedThe page now indicates that results have been submitted, replacing the previous message that no results were posted.SummaryDifference0.3%
- Check82 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
Stay in the know with updates to Pegcetacoplan in ALS Adults: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegcetacoplan in ALS Adults: Efficacy & Safety Clinical Trial page.